Arthur Van Leerberghe is an accomplished leader in clinical research with a proven track record of building strong clinical operations teams and bringing investigational drugs to market. In the industry since 2002, he has contributed to over 7 NDA/sNDA approvals and has extensive inspection and change management expertise, having navigated multiple takeovers and acquisitions. Since 2011, he has mainly been working in small or start-up biotech, specializing in rare diseases. Rising from admin support roles to Executive Director, Arthur has been promoted at least once in every company he’s worked with. A strong team-builder and globetrotter, Arthur has cultivated global teams across the U.S. and Europe, spending multiple years in Brussels (BE), Cambridge (MA) and currently Basel (CH).
